Home / Business and Economy / Pharma Giant's Profit Soars 5.7% in Q1 2026
Pharma Giant's Profit Soars 5.7% in Q1 2026
13 May
Summary
- Net profit rose 5.70% to Rs 277.86 crore in March 2026 quarter.
- Sales increased 2.15% to Rs 995.30 crore for the March 2026 quarter.
- Full-year net profit grew 11.69% to Rs 1035.98 crore for FY2026.
GlaxoSmithKline Pharmaceuticals announced its financial results for the quarter ending March 2026, showcasing a notable increase in profitability and sales. The company's net profit grew by 5.70%, reaching Rs 277.86 crore, compared to Rs 262.87 crore in the same period of the prior year. Sales for the quarter were reported at Rs 995.30 crore, a 2.15% rise from the Rs 974.37 crore recorded in the previous year's quarter.
The positive financial trajectory extended to the full fiscal year ended March 2026. GlaxoSmithKline Pharmaceuticals achieved an 11.69% increase in net profit, amounting to Rs 1035.98 crore, an improvement over the Rs 927.58 crore from the previous fiscal year. The company's full-year sales also saw a moderate increase of 1.93%, totaling Rs 3821.67 crore.
